OptimizeRx Corporation (OPRX)
USD 7.44
(-5.58%)
USD 7.44
(-5.58%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -26.4 Million USD | -114.81% |
| 2022 | -12.29 Million USD | -2648.73% |
| 2021 | 482.22 Thousand USD | 125.51% |
| 2020 | -1.89 Million USD | 48.83% |
| 2019 | -3.69 Million USD | -2150.48% |
| 2018 | 180.13 Thousand USD | 108.46% |
| 2017 | -2.12 Million USD | -34.68% |
| 2016 | -1.58 Million USD | -164.73% |
| 2015 | -597.4 Thousand USD | 41.79% |
| 2014 | -1.02 Million USD | -576.03% |
| 2013 | 215.6 Thousand USD | 159.17% |
| 2012 | -364.34 Thousand USD | 74.94% |
| 2011 | -1.45 Million USD | 21.25% |
| 2010 | -1.84 Million USD | 30.25% |
| 2009 | -2.64 Million USD | -75.53% |
| 2008 | -1.5 Million USD | -323.68% |
| 2007 | -355.94 Thousand USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -5.02 Million USD | 53.88% |
| 2024 Q2 | -3.74 Million USD | 25.45% |
| 2023 FY | -26.4 Million USD | -114.81% |
| 2023 Q3 | -3.55 Million USD | 27.21% |
| 2023 Q4 | -10.9 Million USD | -206.83% |
| 2023 Q1 | -7.06 Million USD | -717.17% |
| 2023 Q2 | -4.88 Million USD | 30.88% |
| 2022 Q1 | -3.76 Million USD | -705.57% |
| 2022 Q4 | -864.34 Thousand USD | 76.99% |
| 2022 FY | -12.29 Million USD | -2648.73% |
| 2022 Q2 | -3.9 Million USD | -3.92% |
| 2022 Q3 | -3.75 Million USD | 3.88% |
| 2021 Q1 | -638.3 Thousand USD | -147.06% |
| 2021 FY | 482.22 Thousand USD | 125.51% |
| 2021 Q2 | 340.13 Thousand USD | 153.29% |
| 2021 Q3 | 38.19 Thousand USD | -88.77% |
| 2021 Q4 | 621.08 Thousand USD | 1526.29% |
| 2020 Q1 | -2.25 Million USD | 2.55% |
| 2020 FY | -1.89 Million USD | 48.83% |
| 2020 Q3 | -176.72 Thousand USD | 83.26% |
| 2020 Q2 | -1.05 Million USD | 53.27% |
| 2020 Q4 | 1.35 Million USD | 867.57% |
| 2019 Q3 | -1.98 Million USD | -513.99% |
| 2019 FY | -3.69 Million USD | -2150.48% |
| 2019 Q1 | 132.16 Thousand USD | 205.36% |
| 2019 Q4 | -2.31 Million USD | -16.66% |
| 2019 Q2 | 480.04 Thousand USD | 263.21% |
| 2018 Q4 | -125.44 Thousand USD | -156.21% |
| 2018 FY | 180.13 Thousand USD | 108.46% |
| 2018 Q3 | 223.17 Thousand USD | -18.43% |
| 2018 Q2 | 273.59 Thousand USD | 243.1% |
| 2018 Q1 | -191.19 Thousand USD | 20.1% |
| 2017 Q3 | -629.65 Thousand USD | -69.92% |
| 2017 Q4 | -239.3 Thousand USD | 61.99% |
| 2017 Q1 | -890.43 Thousand USD | -142.01% |
| 2017 Q2 | -370.56 Thousand USD | 58.38% |
| 2017 FY | -2.12 Million USD | -34.68% |
| 2016 Q1 | -361.82 Thousand USD | 13.01% |
| 2016 Q3 | -249.21 Thousand USD | 58.64% |
| 2016 Q2 | -602.51 Thousand USD | -66.52% |
| 2016 Q4 | -367.93 Thousand USD | -47.63% |
| 2016 FY | -1.58 Million USD | -164.73% |
| 2015 Q2 | -157.52 Thousand USD | -41.29% |
| 2015 Q4 | -415.94 Thousand USD | -575.0% |
| 2015 Q3 | 87.56 Thousand USD | 155.59% |
| 2015 FY | -597.4 Thousand USD | 41.79% |
| 2015 Q1 | -111.49 Thousand USD | -249.43% |
| 2014 Q3 | -394.61 Thousand USD | -645.91% |
| 2014 Q4 | 74.61 Thousand USD | 118.91% |
| 2014 FY | -1.02 Million USD | -576.03% |
| 2014 Q1 | -653.42 Thousand USD | -1373.93% |
| 2014 Q2 | -52.9 Thousand USD | 91.9% |
| 2013 FY | 215.6 Thousand USD | 159.17% |
| 2013 Q1 | -104.88 Thousand USD | -188.19% |
| 2013 Q4 | -44.33 Thousand USD | -514.55% |
| 2013 Q2 | 354.12 Thousand USD | 437.64% |
| 2013 Q3 | 10.69 Thousand USD | -96.98% |
| 2012 Q2 | -76.2 Thousand USD | 74.68% |
| 2012 Q1 | -300.91 Thousand USD | 62.13% |
| 2012 FY | -364.34 Thousand USD | 74.94% |
| 2012 Q4 | 118.93 Thousand USD | 212.04% |
| 2012 Q3 | -106.15 Thousand USD | -39.3% |
| 2011 Q3 | -291.04 Thousand USD | 0.66% |
| 2011 Q1 | -75.43 Thousand USD | 62.99% |
| 2011 Q2 | -292.98 Thousand USD | -288.37% |
| 2011 Q4 | -794.51 Thousand USD | -172.99% |
| 2011 FY | -1.45 Million USD | 21.25% |
| 2010 Q1 | -261.81 Thousand USD | 33.36% |
| 2010 Q3 | -505.21 Thousand USD | 42.29% |
| 2010 FY | -1.84 Million USD | 30.25% |
| 2010 Q2 | -875.36 Thousand USD | -234.35% |
| 2010 Q4 | -203.84 Thousand USD | 59.65% |
| 2009 Q4 | -392.85 Thousand USD | 25.48% |
| 2009 FY | -2.64 Million USD | -75.53% |
| 2009 Q3 | -527.15 Thousand USD | -49.75% |
| 2009 Q2 | -352.01 Thousand USD | 74.4% |
| 2009 Q1 | -1.37 Million USD | -46.58% |
| 2008 Q1 | -215.58 Thousand USD | 0.0% |
| 2008 Q3 | -161.4 Thousand USD | 20.19% |
| 2008 Q2 | -202.24 Thousand USD | 6.19% |
| 2008 FY | -1.5 Million USD | -323.68% |
| 2008 Q4 | -938.08 Thousand USD | -481.19% |
| 2007 FY | -355.94 Thousand USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Omnicell, Inc. | -34.86 Million USD | 24.281% |
| Renalytix Plc | -29.6 Million USD | 10.829% |
| Schrödinger, Inc. | -177.44 Million USD | 85.121% |
| Simulations Plus, Inc. | 6.13 Million USD | 530.627% |
| SOPHiA GENETICS SA | -74.82 Million USD | 64.716% |
| Streamline Health Solutions, Inc. | -19.64 Million USD | -34.38% |
| BrightSpring Health Services, Inc. Common Stock | 147.18 Million USD | 117.938% |
| CareCloud, Inc. | -47.11 Million USD | 43.963% |
| HealthEquity, Inc. | 128.13 Million USD | 120.605% |
| iCoreConnect Inc. | -10.27 Million USD | -156.911% |
| Inovalon Holdings, Inc. | 71.71 Million USD | 136.817% |
| Ontrak, Inc. | -20.67 Million USD | -27.699% |
| Minerva Surgical, Inc. | -30.89 Million USD | 14.555% |
| Nutex Health, Inc. | -31.77 Million USD | 16.907% |
| OneMedNet Corporation | -8.37 Million USD | -215.273% |
| Progyny, Inc. | 62.18 Million USD | 142.457% |
| Augmedix, Inc. | -18.77 Million USD | -40.592% |
| CareCloud, Inc. | -47.11 Million USD | 43.963% |
| GE HealthCare Technologies Inc. | 2.43 Billion USD | 101.084% |
| Sharecare, Inc. | -96.47 Million USD | 72.634% |
| Aclarion, Inc. | -4.87 Million USD | -441.465% |
| CareMax, Inc. | -656.15 Million USD | 95.976% |
| Bullfrog AI Holdings, Inc. Common Stock | -5.36 Million USD | -391.879% |
| Forian Inc. | -5.59 Million USD | -371.879% |
| Bullfrog AI Holdings, Inc. Warrants | -5.36 Million USD | -391.879% |
| HeartBeam, Inc. | -15.31 Million USD | -72.402% |
| GeneDx Holdings Corp. | -163.66 Million USD | 83.868% |
| SCWorx Corp. | -1.45 Million USD | -1719.977% |
| Definitive Healthcare Corp. | -329.8 Million USD | 91.995% |
| 10x Genomics, Inc. | -265.32 Million USD | 90.049% |
| Zhongchao Inc. | -13.28 Million USD | -98.751% |
| Accolade, Inc. | -114.45 Million USD | 76.932% |
| MSP Recovery, Inc. | -559.87 Million USD | 95.284% |
| R1 RCM Inc. | 147.9 Million USD | 117.851% |
| Spok Holdings, Inc. | 21.22 Million USD | 224.372% |
| Privia Health Group, Inc. | 20.64 Million USD | 227.86% |
| EUDA Health Holdings Limited | -3.96 Million USD | -566.533% |
| TruBridge, Inc. | -42.6 Million USD | 38.03% |
| BrightSpring Health Services, Inc. Tangible Equity Unit | 147.18 Million USD | 117.938% |
| Sharecare, Inc. | -96.47 Million USD | 72.634% |
| Health Catalyst, Inc. | -126.89 Million USD | 79.194% |
| GoodRx Holdings, Inc. | -27 Million USD | 2.241% |
| Premier, Inc. | 157.08 Million USD | 116.807% |
| HealthStream, Inc. | 16.01 Million USD | 264.815% |
| Certara, Inc. | -40.77 Million USD | 35.249% |
| GeneDx Holdings Corp. | -163.66 Million USD | 83.868% |
| Ontrak, Inc. | -20.67 Million USD | -27.699% |
| SHL Telemedicine Ltd. | -9 Million USD | -193.157% |
| CareCloud, Inc. | -47.11 Million USD | 43.963% |
| EUDA Health Holdings Limited | -3.96 Million USD | -566.533% |
| HeartBeam, Inc. | -15.31 Million USD | -72.402% |
| Mangoceuticals, Inc. | -9.21 Million USD | -186.387% |
| CareMax, Inc. | -656.15 Million USD | 95.976% |
| Healthcare Triangle, Inc. | -11.34 Million USD | -132.655% |
| National Research Corporation | 40.04 Million USD | 165.93% |
| Aclarion, Inc. | -4.87 Million USD | -441.465% |